Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TGFBR1 | P36897 | 1/20 | 0.50 |
| ▸ | GRM5 | P41594 | 4/20 | 0.46 |
| ▸ | KAT6A | Q92794 | 1/20 | 0.46 |
| ▸ | DRD2 | P14416 | 1/20 | 0.45 |
| ▸ | DRD4 | P21917 | 1/20 | 0.45 |
| ▸ | DRD3 | P35462 | 1/20 | 0.45 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.44 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.43 |
| ▸ | HTR1A | P08908 | 1/20 | 0.42 |
| ▸ | HTR7 | P34969 | 1/20 | 0.42 |
| ▸ | ALOX5AP | P20292 | 1/20 | 0.42 |
| ▸ | FEN1 | P39748 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | CCR1 | P32246 | 2/20 | 0.42 |
| ▸ | CCR5 | P51681 | 2/20 | 0.42 |
| ▸ | CCR8 | P51685 | 2/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | METAP1 | P53582 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2483821 | 0.98 | TGFBR1 (0.51) | TGFBR1GRM5KAT6ADRD2DRD4 | |
| SCHEMBL3774471 | 0.90 | TGFBR1 (0.45) | TGFBR1GRM5KAT6APDK2CYP2A6 | |
| SCHEMBL3773686 | 0.86 | GRM5 (0.47) | TGFBR1GRM5KAT6APDK2CYP2A6 | |
| SCHEMBL3779014 | 0.86 | GRM5 (0.59) | TGFBR1GRM5KAT6APDK2CYP2A6 | |
| SCHEMBL17426491 | 0.86 | KDM4E (0.52) | TGFBR1GRM5PDK2CYP2A6HTR1A | |
| SCHEMBL17311166 | 0.84 | GRM5 (0.48) | TGFBR1GRM5KAT6APDK2CYP2A6 | |
| SCHEMBL29397311 | 0.84 | GRM5 (0.48) | TGFBR1GRM5KAT6APDK2CYP2A6 | |
| SCHEMBL28714019 | 0.82 | KDM4E (0.48) | TGFBR1GRM5PDK2CYP2A6ALOX5AP | |
| SCHEMBL502867 | 0.82 | KDM4E (0.62) | GRM5KAT6ACYP2A6HTR1AHTR7 | |
| SCHEMBL29679578 | 0.82 | KDM4E (0.62) | GRM5KAT6ACYP2A6HTR1AHTR7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3855519-A2 | STABLE AND EFFICIENT ELECTROLUMINESCENT MATERIALS | Universal Display Corporation (US) | 2021-07-28 | — | — | EP | disclosed |
| EP-3428986-B1 | STABLE AND EFFICIENT ELECTROLUMINESCENT MATERIALS | UNIVERSAL DISPLAY CORP (US) | 2021-01-20 | — | — | EP | disclosed |
| US-8603645-B2 | Stable and efficient electroluminescent materials | UNIVERSAL DISPLAY CORPORATION (US) | 2013-12-10 | — | — | US | disclosed |
| US-8449990-B2 | Electroluminescent efficiency | UNIVERSAL DISPLAY CORPORATION (US) | 2013-05-28 | — | — | US | disclosed |
| US-20110060143-A1 | Stable and Efficient Electroluminescent Materials | KWONG RAYMOND | 2011-03-10 | — | — | US | disclosed |
| US-7851072-B2 | Stable and efficient electroluminescent materials | UNIVERSAL DISPLAY CORPORATION (US) | 2010-12-14 | — | — | US | disclosed |
| US-20070003789-A1 | Stable and efficient electroluminescent materials | UNIVERSAL DISPLAY CORPORAITON | 2007-01-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110060143-A1 | Stable and Efficient Electroluminescent Materials | EML4, ITGA5, CHRM5 | TGFBR1 2435/4885GRM5 38/4885KAT6A 3480/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.